These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3842000)

  • 1. Effects of TCV-3B (vinpocetine) on blood viscosity in ischemic cerebrovascular diseases.
    Osawa M; Maruyama S
    Ther Hung; 1985; 33(1):7-12. PubMed ID: 3842000
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of ischemic cerebral accidents with pervincamine].
    Warot P; Caron JC
    Lille Med; 1971 Apr; 16():S 2:6l4-9. PubMed ID: 5162101
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
    Bernini FP; Smaltino F
    Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract]   [Full Text] [Related]  

  • 6. Examinations of the relative fluidity in cerebrovascular disease patients.
    Szobor A; Klein M
    Ther Hung; 1992; 40(1):8-11. PubMed ID: 1585286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory observations on polysaccharide sulphate (PSS) in 282 cases of ischemic cerebrovascular disease.
    Han ZY; Wang QA; Zeng GJ
    Chin Med J (Engl); 1991 Jul; 104(7):562-6. PubMed ID: 1679003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serial angiographic and clinical evaluation of the effects of vicamine in cerebrovascular insufficiency].
    Elefante R; Graziussi G; Baliano G; Granata F
    Minerva Med; 1975 Sep; 66(64):3322-36. PubMed ID: 1178130
    [No Abstract]   [Full Text] [Related]  

  • 9. Testing for cerebrovascular reactivity. A method for estimation of the efficiency of cerebral vasodilating therapy in cerebrovascular disease.
    Sterman-Marinchescu C; Georgescu G; Teodorini E
    Rev Roum Neurol; 1973; 10(4):325-40. PubMed ID: 4588383
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
    Tamaki N; Kusunoki T; Matsumoto S
    Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
    [No Abstract]   [Full Text] [Related]  

  • 12. [The mechanism of the prevention by ethomersol of disorders in erythrocyte deformability in cerebral ischemia and recirculation].
    Plotnikova TM; Firsov NN; Baizova OE
    Eksp Klin Farmakol; 1992; 55(4):29-31. PubMed ID: 1458182
    [No Abstract]   [Full Text] [Related]  

  • 13. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O
    Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transient ischemic attacks].
    Lugaresi E
    Munch Med Wochenschr; 1969 Sep; 111(36):1821-4. PubMed ID: 5820246
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E; D'Alise R; Mea A; Vitagliano A
    Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
    Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical, laboratory and animal experimental observations in treating 288 cases of ischemic cerebrovascular disease with polysaccharide sulfate].
    Han ZY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):99-103, 127. PubMed ID: 2571468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of acute cerebrovascular accidents with the association of dihydroergocornine, dihydroergocristine and dihydroergocryptine with novocaine].
    Bronzini A; Michetti A; Barbieri R
    Clin Ter; 1967 Jun; 41(6):515-22. PubMed ID: 5604097
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
    Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.